Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis.

By K. Fearon, A. Voss, D. Hustead. American Journal of Clinical Nutrition, 2006

731 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Physiology

View Paper: https://www.semanticscholar.org/paper/a98230ccb4394d595ec67e8473044460df3f92ad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. C. Roxburgh
2. W. Mitch

In Oncology

1. C. Roxburgh
2. Vickie E. Baracos

In Physiology

1. C. Roxburgh
2. Vickie E. Baracos
3. K. Fearon
4. D. McMillan
5. J. Morley
6. R. Wolfe
7. S. Anker

Citations in the corpus

• Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer (2009, background): “Systemic inflammation is known to be a key mediator in cachexia (40), and has been associated with poor prognosis in previous studies on pancreatic cancer (41, 42).”
• Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. (2010, background): “This has resulted in a measure of the systemic inflammatory response in the cancer patient being included in the definition of cancer cachexia [9,17,18].”
• Cachexia: a new definition. (2008, background): “Fatigue is frequently associated with cachexia(29,30) as is low muscle (fat-free) mass,(17) and biochemical abnormalities of anemia(31) hypoalbuminemia or inflammation.(3) Because loss of skeletal muscle mass defines cachexia, and because DEXA instruments are commonly found in hospitals, every effor”